Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance - Wikidata - awgldk - TriplyDB

Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance

Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance

http://www.wikidata.org/entity/Q33893385

about

Preclinical rheumatoid arthritis (autoantibodies): an updated review Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE Socioeconomic disparities in the health of african americans with rheumatoid arthritis from the southeastern United States.Insights from populations at risk for the future development of classified rheumatoid arthritis Discovery of biomarkers for systemic lupus erythematosus using a library of synthetic autoantigen surrogates.Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis Environmental and gene-environment interactions and risk of rheumatoid arthritis.Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.A Contra Capture Protein Array Platform for Studying Post-translationally Modified (PTM) Auto-antigenomes.Performance of anti-cyclic citrullinated Peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22 Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis Citrullination of NF-κB p65 promotes its nuclear localization and TLR-induced expression of IL-1β and TNFα.Label-free detection of immune complexes with myeloid cells.The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.The W620 Polymorphism in PTPN22 Disrupts Its Interaction With Peptidylarginine Deiminase Type 4 and Enhances Citrullination and NETosis.Developing better biomarkers for connective tissue disease-associated interstitial lung disease: citrullinated hsp90 autoantibodies in rheumatoid arthritis The dependency on neighboring amino acids for reactivity of anti-citrullinated protein antibodies to citrullinated proteins.Association of serum testosterone and dehydroepiandrosterone sulfate with rheumatoid arthritis: a case control study.Vimentin Diversity in Health and Disease

P2860

Q26863441-06AE2552-C5D0-42EC-B1FC-D3B2540A7A32 Q27003201-4D68A6D9-AE6D-427B-8FEA-8E7C2668408F Q34389411-4BAFD545-967C-4708-B9E7-95C105D5D3B3 Q34604615-3AFD3514-4FEB-4220-9D60-346D85198504 Q35051889-E0D61E56-F74D-4DBA-A8F4-49F26008068A Q36088239-F96BF10E-6EEA-401E-A41E-927D530EDD93 Q36110733-2E1AFFFB-39A7-43DB-BA3A-208AC1F3A004 Q36918405-9ABFC520-A30C-48DA-9CC3-5F8CB98EEBAE Q37076880-0AB3C49D-7AC6-46EC-8153-4A27993B4148 Q37179639-5E7178BE-EFC5-4BF3-BE5D-83E0B37DD871 Q37351587-D4B4F1FF-FDE6-477A-887D-D4DB367544B4 Q37492376-30B4A3D5-2149-4822-9F94-9C5D1C970431 Q38636880-986A1174-B9CB-4AA7-9826-B6954C782BEC Q38787980-6176F229-3054-4029-9E57-0146A8600A36 Q38788500-8B974C83-695E-4CEA-BC65-AE53DBB86567 Q40867605-CA97E54E-E789-4C39-A5B5-B8F46F32D2CD Q40895418-55EC82FC-A5A6-443B-ABAF-B41EC240301F Q42592977-FFB95351-B444-42FC-86B6-BD7C28AFD7CB Q51679039-588F5792-87AD-4FA1-A680-4DD7F4EDE3FE Q55008522-40D929B4-57C7-48B7-8527-FA7893EE79F3 Q58702541-FFA49B43-5F42-490C-97C8-F25756F84E50

P2860

Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance

http://www.wikidata.org/entity/Q33893385

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Antibodies to citrullinated pr ...... pathophysiologic significance

@ast

Antibodies to citrullinated pr ...... pathophysiologic significance

@en

type

label

Antibodies to citrullinated pr ...... pathophysiologic significance

@ast

Antibodies to citrullinated pr ...... pathophysiologic significance

@en

prefLabel

Antibodies to citrullinated pr ...... pathophysiologic significance

@ast

Antibodies to citrullinated pr ...... pathophysiologic significance

@en

P1433

Q33893385-4261626D-5B71-4E59-89AF-67E7C13F8462

P1476

Q33893385-6DC6C129-4692-411D-9089-1091D1212CB4

P2093

Q33893385-70BCEC82-27D5-41A9-9A4F-C02C76D365C0

Q33893385-76C664CD-B046-4480-85D8-F2E23B9F3208

P2860

Q33893385-0227C57F-A2B3-4C33-A26C-2B052453DF32

Q33893385-0304052E-4BEB-4E1F-BB8F-A3B7C8060A56

Q33893385-0F272EFB-588F-4DD4-9B28-174C0D6E2097

Q33893385-0FAA68BC-5EE6-4B1A-936C-30C60684618B

Q33893385-1244BAC6-D4DA-4D5C-BB8F-BBA65FE05390

Q33893385-130C265F-C277-44D3-83F1-031358964A55

Q33893385-1D9D021A-7CC7-468C-9442-EE7ADD8A03EC

Q33893385-22A2E88E-2D79-4213-9148-F566C2D961FA

Q33893385-29238953-E75E-4DC6-884F-6F6A985EE25C

Q33893385-2BEB5635-94AF-4985-B521-0282428357FD

P2888

Q33893385-F61386E2-993D-4E66-BEFC-DD3581021E4C

P304

Q33893385-AF2D03AD-7036-43FD-9455-B298947CAAF5

P31

Q33893385-9C5C3A90-F5DC-4B65-9BB1-FA050F2C27D9

P356

Q33893385-12AEC696-E9CE-4FF1-B899-4374719992EF

P433

Q33893385-FC246D61-FF22-4410-BD79-B1A4DB58E503

P478

Q33893385-94719578-9AC2-448D-A88D-121527C2E532

P577

Q33893385-6E75D836-2C8F-44BD-8338-1BC5B3AA02AD

P6179

Q33893385-F4893CB0-8A7E-46F0-A29F-DC2153B85928

P698

Q33893385-7E2BD7FD-BA95-4731-BBEC-DFC46B0077D4

P921

Q33893385-BB728269-D1DF-48A9-AEAF-73E0FF853D06

P932

Q33893385-5C1ACC94-44B8-4A88-9760-F8A8BF970BE0

P356

S11926-011-0193-7

P1433

Current Rheumatology Reports

P1476

Antibodies to citrullinated pr ...... pathophysiologic significance

@en

P2093

Kevin Deane

http://www.w3.org/2001/XMLSchema#string

M Kristen Demoruelle

http://www.w3.org/2001/XMLSchema#string

P2860

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies

Anti-keratin antibodies in rheumatoid arthritis

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis

Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis.

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

The anti-cyclic citrullinated peptide response in tuberculosis patients is not citrulline-dependent and sensitive to treatment.

P2888

s11926-011-0193-7

P304

421-430

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11926-011-0193-7

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1053194505

http://www.w3.org/2001/XMLSchema#string

P698

21713412

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

P932

4095867

http://www.w3.org/2001/XMLSchema#string